Remove authors drug-topics-staff
article thumbnail

The Power of an End-to-End Controlled Substance Management Program

Omnicell

Gee Mathen, Director Pharmacy Clinical Applications & Technical Services, Texas Children Hospital When it comes to the crippling costs of diversion, the numbers don’t lie: 1 in 10 healthcare workers will abuse drugs, and studies show that the annual impact is upwards of $72.5

article thumbnail

Engaging change: Connecting patients and regulators can move the dial on drug development

pharmaphorum

Regulators are increasingly asking drug developers to include the patient voice in submissions, but the best way to go about this is less clear-cut. In the United States, learning how to navigate forums such as the FDA’s listening sessions and patient-focused drug development (PFDD) meetings could be the key to “truly moving the dial”.

FDA 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why pharmacy technicians are important in education

The Checkup by Singlecare

“Each class usually covers a different area, such as brand and generic drugs, pharmacy law and state-specific laws, mathematics, how to read a prescription, proper labeling, etc.,” During the COVID-19 pandemic, many states authorized pharmacy technicians to administer vaccines with proper training and certification. Smith says.

article thumbnail

The Case for Targeted Marketing for Independent Pharmacy Owners

DiversifyRx

Use targeted marketing to showcase your staff’s knowledge, the quality of your products, and the uniqueness of your pharmacy’s care. Tips and advice on health topics related to your special services can help cement your reputation as a trustworthy authority in your community. It’s okay to step into that role.

article thumbnail

Regulatory Insights from 2022 ISPE Annual Meeting

ISPE

ISPE’s regulatory volunteer groups are charged with bringing visibility and solutions to major challenges faced by the industry with regard to regulatory/quality matters, and facilitating the flow of information between ISPE members and global Health Authorities.

FDA 52
article thumbnail

Challenges & Opportunities in Emerging Digital Health Technologies

ISPE

As digital health sits at the intersection of technical, scientific, and regulatory disciplines involving medical devices, drugs, and biologics, the successful development of novel DHTs will require significant collaboration with health care stakeholders to overcome regulatory, technical, and life-cycle management challenges.

article thumbnail

Decision Making Has Always Been In My DNA — Regardless If I Have The Right To Make The Call

The Happy PharmD

As an instructor in one department and a career representative in another, I was a staff person in each of these departments. But I was a staff member- not the manager. I soon realized that it was hard to go from the management mentality to the staff member mentality. He also had the drug’s package insert. Neither did I.